What causes Acute Generalized Exanthematous Pustulosis (AGEP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Acute Generalized Exanthematous Pustulosis (AGEP)?

AGEP is primarily a drug-induced severe cutaneous adverse reaction, with antibiotics (especially beta-lactams) being the most common culprits, though infections, vaccinations, and other substances can also trigger this condition. 1, 2, 3

Primary Causative Agents

Medications (Most Common Cause)

Antibiotics are the leading cause of AGEP, particularly:

  • Beta-lactam antibiotics (penicillins, cephalosporins) are the most frequently implicated drugs 2, 3
  • Other antibiotics also commonly trigger AGEP 1, 3

Additional medication classes that cause AGEP include:

  • Antifungal agents 2
  • Non-steroidal anti-inflammatory drugs (NSAIDs) 2
  • Analgesics 2
  • Antiarrhythmic drugs 2
  • Anticonvulsant medications 2
  • Antidepressant drugs 2

Non-Drug Triggers

Less common causes of AGEP include:

  • Infections (viral or bacterial) 1, 3
  • Vaccinations 1
  • Ingestion of various substances 1
  • Spider bites 1

Pathophysiological Mechanism

AGEP is mediated by drug-specific T cells that produce numerous cytokines, leading to neutrophilic infiltration and pustule formation 4. Specifically:

  • The neutrophil attractant chemokine IL-8 is involved in AGEP pathogenesis, killing target cells via both perforin and FAS-mediated pathways 5
  • Drug-specific T cells produce cytokines that mediate the development of intracorneal, subcorneal, or intraepidermal pustules 4

Genetic susceptibility may play a role:

  • Individuals with mutations in IL-36RN may be at increased risk of developing AGEP 4
  • However, genetic predisposition is not fully understood 4

Clinical Timing

AGEP typically develops rapidly after drug exposure:

  • Onset occurs within 48 hours of ingesting the causative medication in most cases 3
  • The reaction is characterized by acute onset of fever, pustulosis, and leukocytosis 3

Key Clinical Pitfall

Cross-reactivity within the same drug class can occur, meaning patients who develop AGEP from one beta-lactam antibiotic may react to other beta-lactams 2. This is critical for preventing recurrence when selecting alternative medications.

References

Research

Acute generalized exanthematous pustulosis (AGEP). Case report.

Revista do Instituto de Medicina Tropical de Sao Paulo, 2005

Research

Acute generalized exanthematous pustulosis (AGEP): A review and update.

Journal of the American Academy of Dermatology, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.